Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?

被引：41

作者：

Amir, Eitan ^{[1
]}

Clemons, Mark ^{[2
]}

机构：

[1] Princess Margaret Hosp, Div Med Oncol, Toronto, ON M4X 1K9, Canada

[2] Ottawa Hosp, Ctr Canc, Div Med Oncol, Ottawa, ON, Canada

来源：

LANCET ONCOLOGY | 2009年 / 10卷 / 10期

关键词：

ESTROGEN; BONE;

D O I：

10.1016/S1470-2045(09)70295-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：933 / 935

页数：3

共 14 条

[1] Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study [J].

Amir, E. ;

Freedman, O. ;

Simmons, C. ;

Miller, N. ;

Geddie, W. ;

DeBorja, A. ;

Maung, H. ;

Gianfelice, D. ;

Murphy, K. ;

Clemons, M. .

BREAST CANCER RESEARCH, 2009, 11 :S20-S20

[2] Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies [J].

Amir, E. ;

Ooi, W. S. ;

Simmons, C. ;

Kahn, H. ;

Christakis, M. ;

Popovic, S. ;

Kalina, M. ;

Chesney, A. ;

Singh, G. ;

Clemons, M. .

CLINICAL ONCOLOGY, 2008, 20 (10) :763-768

[3] VARIABILITY OF ESTROGEN RECEPTORS IN METASTATIC BREAST-CANCER [J].

BRENNAN, MJ ;

DONEGAN, WL ;

APPLEBY, DE .

AMERICAN JOURNAL OF SURGERY, 1979, 137 (02) :260-262

[4] Technical pitfalls potentially affecting diagnoses in immunohistochemistry [J].

Bussolati, G. ;

Leonardo, E. .

JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (11) :1184-1192

[5] PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer [J].

Dehdashti, Farrokh ;

Mortimer, Joanne E. ;

Trinkaus, Kathryn ;

Naughton, Michael J. ;

Ellis, Matthew ;

Katzenellenbogen, John A. ;

Welch, Michael J. ;

Siegel, Barry A. .

BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (03) :509-517

[6] Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging [J].

Dijkers, Eli C. F. ;

Kosterink, Jos G. W. ;

Rademaker, Anna P. ;

Perk, Lars R. ;

van Dongen, Guus A. M. S. ;

Bart, Joost ;

de Jong, Johan R. ;

de Vries, Elisabeth G. E. ;

Lub-de Hooge, Marjolijn N. .

JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) :974-981

[7] ESTROGEN AND PROGESTERONE-RECEPTOR CONCORDANCE BETWEEN PRIMARY AND RECURRENT BREAST-CANCER [J].

LI, BDL ;

BYSKOSH, A ;

MOLTENI, A ;

DUDA, RB .

JOURNAL OF SURGICAL ONCOLOGY, 1994, 57 (02) :71-77

[8] Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer [J].

Mann, GB ;

Fahey, VD ;

Feleppa, F ;

Buchanan, MR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5148-5154

[9] Circulating tumor cells in breast cancer:: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity [J].

Müller, V ;

Stahmann, N ;

Riethdorf, S ;

Rau, T ;

Zabel, T ;

Goetz, A ;

Janicke, F ;

Pantel, K .

CLINICAL CANCER RESEARCH, 2005, 11 (10) :3678-3685

[10] Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol [J].

Peterson, Lanell M. ;

Mankoff, David A. ;

Lawton, Thomas ;

Yagle, Kevin ;

Schubert, Erin K. ;

Stekhova, Svetlana ;

Gown, Allen ;

Link, Jeanne M. ;

Tewson, Timothy ;

Krohn, Kenneth A. .

JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (03) :367-374

← 1 2 →